SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Atrion Corporation (ATRI) trades at a trailing P/E of 41.7. Trailing earnings yield is 2.40%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 41.7).
- Trailing Earnings Yield 2.40% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 52/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ATRI
Valuation Multiples
P/E (TTM)41.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.78
EV/EBITDA0.0
Per Share Data
EPS (TTM)$11.02
Book Value / Share$0.00
Revenue / Share$96.15
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.40%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$14.08 |
$140.76M |
$27.81M |
19.8% |
| 2015 |
$15.47 |
$145.73M |
$28.93M |
19.8% |
| 2016 |
$14.85 |
$143.49M |
$27.58M |
19.2% |
| 2017 |
$19.71 |
$146.6M |
$36.59M |
25% |
| 2018 |
$18.44 |
$152.45M |
$34.26M |
22.5% |
| 2019 |
$19.73 |
$155.07M |
$36.76M |
23.7% |
| 2020 |
$17.44 |
$147.59M |
$32.12M |
21.8% |
| 2021 |
$18.18 |
$165.01M |
$33.06M |
20% |
| 2022 |
$19.56 |
$183.51M |
$35.01M |
19.1% |
| 2023 |
$11.02 |
$169.33M |
$19.41M |
11.5% |
